Epstein Secrets

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

re Will Not Compromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety

ipates "Some Form" Of 380 Vaccine Resumption By Friday. NIAID Director Fauci, on CNN's State Of The Union (4/18, 644K), discussed the pause on the Johnson & Johnson vaccine and overall vaccination efforts in the US. When asked about the decision to pause, Fauci said, "Because you want to make sure that you have

France Will Lift Restrictions For Vaccinated Travelers Starting In May. • COVID Deaths, New Cases Declining In Britain. • Ontario To Expand Use Of AstraZeneca Vaccine This Week. • Brazil's Daily COVID Death Toll Is World's Highest. • India Records 200K New COVID Cases For Ninth Straight Day. • Iran's Dai

s-may- ready-early-2021/5478232002/> (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Modema and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guid

fe-cheap-doses-may- ready-early-2021/5478232002/> (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Modema and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized

2/22, Jamison, 10.52M) reports that in Baltimore, Emergent BioSolutions "is manufacturing almost all of the yet-to-be approved Johnson & Johnson and AstraZeneca coronavirus vaccines for the U.S. population - an anticipated hundreds of millions of doses in the coming months." But "in a sign of the complexiti

uccia, Subscription Publication, 8.41M), Politico (1/26, Cancryn, Roubein, 6.73M), and The Hill (1/26, Sullivan, Samuels, 5.69M) also have reports. Johnson & Johnson Expects To Report Vaccine Data Next Week. Reuters (1/26, Mishra, O'Donnell) reports that on Tuesday, Johnson & Johnson "said it expected to report

mbers states are struggling to get their vaccine rollout going at top speed." The AP says "the hardening of its position came days after it accused AstraZeneca of failing to guarantee the delivery of coronavirus vaccines without a valid explanation. It also had expressed displeasure over vaccine delivery de

ew surge." Although the Times adds "experts aren't sure why vaccination rates have begun falling, or whether vaccine hesitancy, an issue before the Johnson & Johnson pause, is entirely to blame," Lilia Luciano reported on the CBS Weekend NewsVi (4/25, lead story, 2:30, Duncan, 1.24M) that a new CBS News poll "fin

essional India Caucus Vice Chair, "welcomed the announcement" but urged Biden to "give India the United States' unused COVID-19 vaccines doses from AstraZeneca." Khanna said the Administration should "use the U.S. military and get as much oxygen and AstraZeneca doses to India as fast as we can." According

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

re Will Not Compromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety

ine Use. The Washington Post (4/22, Al, McGinley, Sun, 10.52M) reports, "Federal health authorities are leaning toward recommending that use of the Johnson & Johnson coronavirus vaccine resume, possibly as soon as this weekend - a move that would include a new warning about a rare complication involving blood cl

on within just a few days." In his Washington Post (4/22, 10.52M) column, Fareed Zakaria argues the pause, and Europe's temporary suspension of the AstraZeneca vaccine, "are fueling many people's fears EFTA00150536 about vaccine safety, perpetuating conspiracy theories and wasting precious time at a momen

ipates "Some Form" Of HO Vaccine Resumption By Friday. NIAID Director Fauci, on CNN's State Of The UnionVi (4/18, 644K), discussed the pause on the Johnson & Johnson vaccine and overall vaccination efforts in the US. When asked about the decision to pause, Fauci said, "Because you want to make sure that you have

ft Restrictions For Vaccinated Travelers Starting In May. EFTA00150638 • COVID Deaths, New Cases Declining In Britain. • Ontario To Expand Use Of AstraZeneca Vaccine This Week. • Brazil's Daily COVID Death Toll Is World's Highest. • India Records 200K New COVID Cases For Ninth Straight Day. • Iran's Dai

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

re Will Not Compromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety